Elanco Animal Health (ELAN) Cash & Equivalents Growth (1y) (2018 - 2026)
Elanco Animal Health (ELAN) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | 120.45% |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | 12.78% |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | -32.64% |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | - |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | 138.97% |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | 37.30% |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | -12.11% |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | -4.65% |
| 10 | Vireo Growth | 10.64 Bn | 10.52 Bn | 59.30 Mn | 42.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.11% |
| Dec 31, 2025 | 16.45% |
| Sep 30, 2025 | 3.06% |
| Jun 30, 2025 | 29.57% |
| Mar 31, 2025 | 41.16% |
| Dec 31, 2024 | 32.95% |
| Sep 30, 2024 | 32.79% |
| Jun 30, 2024 | 13.35% |
| Mar 31, 2024 | 8.49% |
| Dec 31, 2023 | 2.03% |
| Sep 30, 2023 | -19.78% |
| Jun 30, 2023 | -27.61% |
| Mar 31, 2023 | -7.02% |
| Dec 31, 2022 | -45.92% |
| Sep 30, 2022 | 1.55% |
| Jun 30, 2022 | -12.59% |
| Mar 31, 2022 | -33.59% |
| Dec 31, 2021 | 28.89% |
| Sep 30, 2021 | -31.36% |
| Jun 30, 2021 | -58.30% |